The US FDA has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease.

The new vaccine is a combination of GSK’s already-approved vaccines Bexsero and Menveo and is designed to protect against meningitis and blood poisoning caused by the A, B, C, W, and Y ...

with a safety profile consistent with Bexsero and Menveo. GSK’s chief scientific officer, Tony Wood, said that the results show the vaccine protects against “the broadest panel of circulating ...

Two vaccines are required. The first is called Menveo or Menquadfi, and it protects against meningococcal types (called serogroups) A, C, W, and Y. Depending on the vaccine used and when the ...

Une campagne massive de vaccination contre la méningite commence, ce lundi 3 mars, dans la métropole de Rennes après la découverte de six cas d’infections.

In some cases, this disease can become very serious and life-threatening. Fortunately, a vaccine can protect against this disease and its more serious consequences. The meningococcal vaccine can help ...

Feb. 26, 2025 — Pre-existing immunity against seasonal H1N1 flu might help explain why most reported human cases of H5N1 bird flu in the U.S. have not resulted in lethal ...